Malaysia Pharmaceuticals and Healthcare Report Q1 2015

Business Monitor International
December 24, 2014
139 Pages - SKU: BMI5432436
Countries covered: Malaysia

Malaysia Pharmaceuticals and Healthcare Report Q1 2015

BMI View: Malaysia's 2015 budget reinforces our upbeat outlook on the country's pharmaceutical market.Rising healthcare expenditure plans to improve medical access and efforts to mitigate the impact of theGoods and Service Tax on medicine prices will provide companies with significant revenue-earningopportunities. However, downside risks to our outlook include further economic slowdown forecast for2015, worries of an increasing number of imitation drugs and growing political differences within both theopposition and ruling coalitions.

Headline Expenditure Projections

Pharmaceuticals: MYR6.60bn (USD2.10bn) in 2013 to MYR7.22bn (USD2.25bn) in 2014; +9.3 % inlocal currency and +7.6% in US dollar terms. Forecast revised down from last quarter to better suitcurrent market conditions.



More Prescription Drugs reports by Business Monitor International

Namibia Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Namibia Pharmaceuticals and Healthcare Report Q1 2015BMI View: Recent comments by the public relations officer of the Ministry of Health and Social Services,Ester Paulus, that ...
Moldova Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Moldova Pharmaceuticals and Healthcare Report Q1 2015BMI View: The Moldovan pharmaceutical market presents limited opportunities for investors in the shortterm, but with the country opening ...
Ghana Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Ghana Pharmaceuticals and Healthcare Report Q1 2015BMI View: We anticipate that the continuing roll-out of biometric registration and expansion of thecommunity-based health planning and services ...
Central America Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Central America Pharmaceuticals and Healthcare Report Q1 2015BMI View: Central America will continue to offer revenue-generating opportunities for multinationalpharmaceutical companies. An ageing population, favourable tax ...
See all reports like this >>

More Malaysia Prescription Drugs reports

Pharmaceuticals and Healthcare Report - Malaysia Q4 2014 by Business Monitor International
Pharmaceuticals and Healthcare Report - Malaysia Q4 2014BMI View: The Malaysian pharmaceutical and healthcare markets are set to grow significantly. Promisinglong-term economic growth, local government ...
Antibiotics Market in Malaysia to 2016 by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Malaysia. The study provides essential market ...
The Pharmaceutical Market: Malaysia by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
The Pharmaceutical Market: Malaysia (pdf/xls) by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!